Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

QPT

Quest PharmaTech (QPT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:QPT
DataOraFonteTitoloSimboloCompagnia
30/05/202423:00PR Newswire (Canada)Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New DirectorTSXV:QPTQuest PharmaTech Inc
30/01/202423:00PR Newswire (Canada)Quest Receives Cash Dividend Payment from OncoQuestTSXV:QPTQuest PharmaTech Inc
23/01/202423:49PR Newswire (Canada)Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical BenefitsTSXV:QPTQuest PharmaTech Inc
13/09/202322:15PR Newswire (Canada)Quest PharmaTech Provides Corporate UpdateTSXV:QPTQuest PharmaTech Inc
14/07/202322:30PR Newswire (Canada)Quest PharmaTech Announces Results from AGMTSXV:QPTQuest PharmaTech Inc
10/07/202322:30PR Newswire (Canada)Quest PharmaTech Provides Product Development UpdateTSXV:QPTQuest PharmaTech Inc
07/06/202313:52PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - QPTTSXV:QPTQuest PharmaTech Inc
07/06/202313:50PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - QPTTSXV:QPTQuest PharmaTech Inc
06/06/202323:15PR Newswire (Canada)Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.TSXV:QPTQuest PharmaTech Inc
06/06/202314:03PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - QPTTSXV:QPTQuest PharmaTech Inc
06/06/202314:00PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - QPTTSXV:QPTQuest PharmaTech Inc
28/09/202223:00PR Newswire (Canada)Quest PharmaTech Announces Sale of Bioceltran Investment and Return of Photodynamic Therapy Technology LicenseTSXV:QPTQuest PharmaTech Inc
01/09/202123:15PR Newswire (Canada)OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of Recurrent Ovarian CancerTSXV:QPTQuest PharmaTech Inc
01/06/202121:00PR Newswire (Canada)Quest PharmaTech announces two presentations by OncoQuest Pharmaceuticals, Inc. at the 2021 Annual Meeting of the American As...TSXV:QPTQuest PharmaTech Inc
27/03/202100:14PR Newswire (Canada)Quest Provides Update to Immunotherapy Asset Transfer Between OncoQuest Inc. and OncoQuest Pharmaceuticals Inc.TSXV:QPTQuest PharmaTech Inc
09/11/202023:30PR Newswire (Canada)Quest Announces that OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical Trial, FLORA-5, of Company's Lead...TSXV:QPTQuest PharmaTech Inc
04/06/202023:05PR Newswire (Canada)Quest Provides Corporate UpdateTSXV:QPTQuest PharmaTech Inc
02/06/202022:11PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - QPTTSXV:QPTQuest PharmaTech Inc
02/06/202022:08PR Newswire (Canada)IIROC Trading Resumption - QPTTSXV:QPTQuest PharmaTech Inc
04/05/202017:16PR Newswire (Canada)MISE À JOUR - Suspension de la négociation par l'OCRCVM - QPTTSXV:QPTQuest PharmaTech Inc
04/05/202017:10PR Newswire (Canada)UPDATE - IIROC Trading Halt - QPTTSXV:QPTQuest PharmaTech Inc
01/05/202022:30PR Newswire (Canada)Quest PharmaTech Announces Results from its April 28, 2020 AGMTSXV:QPTQuest PharmaTech Inc
22/04/202019:10PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - QPTTSXV:QPTQuest PharmaTech Inc
22/04/202019:07PR Newswire (Canada)IIROC Trading Halt - QPTTSXV:QPTQuest PharmaTech Inc
22/04/202018:47PR Newswire (Canada)OncoQuest Signs a Definitive Agreement to Sell Drug Portfolio to Dual Industrial for U.S. $300 Million and Commitment to Fund...TSXV:QPTQuest PharmaTech Inc
24/03/202011:00PR Newswire (Canada)OncoQuest Announces Publication of Two Reports Related to Oregovomab Phase 2 Clinical Trial, the Company's Lead Investigation...TSXV:QPTQuest PharmaTech Inc
13/03/202022:01PR Newswire (Canada)OncoQuest Announces a U.S.$50 Million Investment by KOSDAQ listed Dual Industrial Co. Ltd.TSXV:QPTQuest PharmaTech Inc
25/09/201913:00PR Newswire (Canada)OncoQuest Receives "Notice of Allowance" for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy ...TSXV:QPTQuest PharmaTech Inc
25/01/201918:50PR Newswire (Canada)OncoQuest Lays the Groundwork for Commencement of Phase 3 Study in Frontline Ovarian CancerTSXV:QPTQuest PharmaTech Inc
20/12/201801:26PR Newswire (Canada)Quest PharmaTech Adopts Amendment to By-laws Requiring Advance Notice of Nomination of DirectorsTSXV:QPTQuest PharmaTech Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:QPT
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network